Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
79.4
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (11)
○ MHRA GMP
Quick Facts: Curia (RNA/Advanced)
- Signal Score
- 79.4/100 (as of 2026-04-02)
- Quality Compliance
- 99.9/100
- Headquarters
- Albany, NY · Albuquerque, NM
- Modalities
- mRNA, Oligonucleotide, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
99.9
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-12-02)
EMA GMP Certificates11 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Oligonucleotide, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
63.0
2 manufacturing sites
Sites: Albany, NY, Albuquerque, NM
Source: SEC EDGAR, press monitoring, company profiles
2 manufacturing sites
2 manufacturing sites
FDA Inspection History
2025-12
2025-05
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-12-02 | Springfield, Missouri | Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-05-09 | Albany, New York | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Apr 05, 2026
EMA GMP Compliance 11 certificates
2025-11
2025-04
2025-03
2024-12
2024-06
2023-05
2023-02
2023-02
2023-02
2023-02
2023-02
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| 25MPP072HFR01 | Curia France S.A.S. | France | 2025-11-27 | COMPLIANT |
| IT-API/120/H/2025 | Curia Italy S.r.l. | Italy | 2025-04-11 | COMPLIANT |
| 25MPP015HFR01 | Curia France S.A.S. | France | 2025-03-28 | COMPLIANT |
| IT-API/29/H/2025 | Curia Italy S.r.l. | Italy | 2024-12-05 | COMPLIANT |
| 24MPP026HFR01 | Curia France S.A.S. | France | 2024-06-07 | COMPLIANT |
| IT-API/20/H/2024 | Curia Italy S.r.l. | Italy | 2023-05-25 | COMPLIANT |
| M00611-03/23/02 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-02/23/01 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| 10350-004/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-01/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-03/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Apr 05, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 81.6
mRNA, Oligonucleotide, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score: 81.6
mRNA, Plasmid, Biologics